GlassScriptPhysician profile
Ashley A Goad
NPI 1326776162
$2,343.12
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $216 · 2023: $1,153 · 2024: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,127.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $574.55 | 2022-2024 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Lilly USA, LLC | $390.47 | 2022-2024 | Mounjaro, Trulicity, Zepbound |
| Glaxosmithkline, LLC. | $299.16 | 2022-2024 | Trelegy Ellipta |
| Abbvie INC. | $236.52 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $176.53 | 2023-2024 | Trintellix |
| Novo Nordisk INC | $144.07 | 2022-2024 | Ozempic, Rybelsus |
| Pfizer INC. | $127.63 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $97.77 | 2022-2024 | Farxiga, Airsupra, Breztri |
| Phathom Pharmaceuticals, INC. | $60.54 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $58.55 | 2022-2023 | Belsomra, Steglatro, Verquvo |
| Exact Sciences Corporation | $41.42 | 2023 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $40.16 | 2023 | Auvelity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.81 | 2023-2024 | Xifaxan |
| Ibsa Pharma INC. | $21.15 | 2023 | Tirosint, Licart |
| Azurity Pharmaceuticals, INC. | $19.67 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.12 | 2023 | Repatha, Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Goad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.